COMMUNIQUÉS West-GlobeNewswire

Pycnogenol® Brings a “Less-is-More” Approach to the Women’s Health Stack
16/06/2026
Clinically studied French maritime pine bark extract supports skin, circulation, menopause wellness and mobility in one multifunctional ingredient GENEVA, June 16, 2026 (GLOBE NEWSWIRE) -- From hydration and collagen [...]
Microbot Medical® Enters Into an Agreement to Expand Access for America’s Veteran and Military Patient Populations
16/06/2026
The agreement with Lovell Government Services creates opportunities to sell the LIBERTY® System at more than 2,000 government facilities, including those administered by the U.S. Department of Veterans Affairs, the [...]
Syncromune Presents Multi-Modal Efficacy Assessment Framework at Inaugural Gustave Roussy Intratumoral Immunotherapy Symposium
16/06/2026
FORT LAUDERDALE, Fla. and WEST DES MOINES, Iowa, June 16, 2026 (GLOBE NEWSWIRE) -- Syncromune, Inc., a privately held clinical-stage biopharmaceutical company developing SYNC-T™, an investigational in situ multi-target [...]
Entera Reports Robust Preclinical Data for EB612 (Oral LA-PTH(1-34)) for Hypoparathyroidism and EB618 (Oral GLP-1/Glucagon) for Obesity at ENDO 2026
16/06/2026
EB612, a first-in-class long-acting PTH(1-34) oral peptide for hypoparathyroidism, produced robust bioavailability and sustained increases in calcium across three preclinical models; IND is expected in late 2026 EB618, [...]
Erdem Hospital Highlights Emotional Wellbeing as Part of Patient Care with London Wellness Event
16/06/2026
The free London gathering reflects Erdem Hospital’s belief that recovery is more than physical, with guided breathing, gentle movement, and human connection playing an important role in the patient’s journey ISTANBUL, [...]
Intelligent Bio Solutions Initiates Clinical Study Supporting FDA Clearance and Planned U.S. Market Entry
16/06/2026
Interference Study designed to validate system specificity in the presence of potentially interfering substances commonly encountered in real-world settings Company expects to complete the study by mid-July 2026, with [...]
Through the MUHC Foundation, one family helps fuel breakthrough in rare cancer research
16/06/2026
MONTREAL, June 16, 2026 (GLOBE NEWSWIRE) -- One family’s generosity is helping drive a major breakthrough in rare cancer research at the MUHC. Through the MUHC Foundation’s SDR Project, Jim Hindley, his granddaughter [...]
First Steps Developmental Services Expands School Partnership Program to Support Massachusetts Students and Educators
16/06/2026
Behavior Technician support, BCBA consultation, and school-based behavioral services help Massachusetts schools maintain continuity of support for students during staffing shortages, extended absences, and other [...]
Sanuwave Health Updates Second Quarter 2026 Guidance
16/06/2026
Sanuwave updates guidance for Q2 2026 to $8.5 - $9.5 million Company on pace for record unit sales of applicators in Q2 Market disruption impacting Ultramist system sales EDEN PRAIRIE, Minn., June 16, 2026 (GLOBE [...]
Adial Pharmaceuticals Expands Executive Leadership Team and Closes PIPE Financing
16/06/2026
GLEN ALLEN, Va., June 16, 2026 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (Nasdaq: ADIL) (“Adial” or the “Company”) today announced that the Company’s Compensation Committee and Board of Directors granted Matthew [...]
MultiValent Biotherapies Launches with $27 Million Series A Financing to Advance Development of Targeted Prostate Cancer Drug Conjugate
16/06/2026
- First closing of $27 million Series A financing - - Funding will support Phase 1b/2a clinical trial of MVB-101, a prostate-specific membrane antigen x folate receptor alpha (PSMA x FRα) targeted drug conjugate - - [...]
Sharecare selected by Georgia Department of Community Health to advance rural health transformation through GREAT Health Program
16/06/2026
Company’s next-generation digital health experience, AskMD, to help Georgians better understand health risks, improve outcomes, and foster long-term well-being ATLANTA, June 16, 2026 (GLOBE NEWSWIRE) -- Sharecare, the [...]
Picard Medical and SynCardia to Present New In Vivo Emperor Total Artificial Heart Data and Patient Outcome Research at ASAIO 2026
16/06/2026
Two scientific presentations highlight next-generation innovation and patient outcomes with total artificial heart support TUCSON, Ariz., June 16, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (“ [...]
Cingulate Issued First U.S. Patent for Lead ADHD Asset CTx-1301
16/06/2026
Exclusivity Extended into December 2042 KANSAS CITY, Kan., June 16, 2026 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug [...]
Creative Medical Technology Holdings, Inc. Advances Project PHOENIX into Nationwide AI Driven Virtual Data Collection Phase for U.S. Veterans Exposed to Burn Pits and Toxic Hazards
16/06/2026
The regulatory approved CELZ-Biodefense platform is designed to scale to at least 1,000 veterans through AI-enabled mobile-app data collection and field-capable logistics Proprietary CELZ-Biodefense Toxic Exposure Atlas [...]
King Faisal Specialist Hospital Presents Robotic Surgery as a Model for Innovation-Driven Specialized Care at HLTH Europe 2026
16/06/2026
AMSTERDAM, June 16, 2026 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSH) is highlighting its leadership in robotic surgery during its participation at HLTH Europe 2026, taking place from [...]
Calidi Biotherapeutics Receives Positive Pre-IND Feedback from US FDA for CLD-401 Indicating Agreement on its Current Development Strategy as it Advances Towards a First-in-Human Study
16/06/2026
IND enabling studies with CLD-401 to continue with IND submission targeted by end of 2026 as Calidi continues to explore regulatory filing for CLD-401 in Australia in parallel SAN DIEGO, June 16, 2026 (GLOBE NEWSWIRE [...]
Quoin Pharmaceuticals Announces Positive Clinical Update from Ongoing Pediatric Netherton Syndrome Compassionate Use Program
16/06/2026
Four of Six Patients Participating in the Compassionate Use Program Were Classified as ‘Improved’ or ‘Significantly Improved’ from Baseline Assessment Across Key Clinical Endpoints All Six Patients Are Younger than 10 [...]
Outlook Therapeutics Announces FDA Acceptance of Resubmitted Biologics License Application for ONS-5010/LYTENAVA™ (bevacizumab-vikg) as a Treatment for Wet AMD
16/06/2026
Prescription Drug User Fee Act (PDUFA) goal date of July 29, 2026 ISELIN, N.J., June 16, 2026 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard [...]

Pages